FDA commissioner nominee Heidi Overton faces abortion pill questioning

On 24 September 2026, senators questioned FDA commissioner nominee Heidi Overton, an outspoken abortion critic, during her confirmation hearing. Overton would oversee an ongoing FDA safety review of mifepristone, the nation's leading abortion pill, but indicated that the agency's existing review would determine any regulatory changes.